Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2026-01-01 @ 1:10 PM
Study NCT ID:
NCT02006732
Status:
COMPLETED
Last Update Posted:
2016-01-20
First Post:
2013-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11
Start Date Type:
None
Primary Completion Date:
2014-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-11
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-14
First Submit QC Date:
None
Study First Post Date:
2013-12-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-23
Results First Submit QC Date:
None
Results First Post Date:
2016-01-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-12-10
Last Update Post Date:
2016-01-20
Last Update Post Date Type:
ESTIMATED